-
1
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
Published 2024-07-01Subjects: Get full text
Article -
2
Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge.
Published 2025-01-01“…In this study, 4 human monoclonal antibodies (hmAbs) derived from convalescent SFTS patients' lymphocytes based on human single-chain variable fragment antibody libraries were tested for their neutralizing activities in cells and their treatment effect in animals individually and in pair combinations. …”
Get full text
Article -
3
-
4
Role of Monoclonal Antibodies in the Treatment of Asthma
Published 2013-01-01“…New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have included humanized monoclonal antibodies (hMabs).…”
Get full text
Article -
5
Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review
Published 2025-02-01“…Dupilumab, a human monoclonal antibody targeting for interleukin (IL)-4/13 receptor α chain, is widely applied in type 2 inflammation diseases treatment. …”
Get full text
Article -
6
Interstitial Granulomatous Drug Reaction to Ustekinumab
Published 2022-01-01“…Ustekinumab is a human monoclonal antibody that targets inflammatory cytokines IL-12 and IL-23 and has been have shown to be effective in treating IGDR. …”
Get full text
Article -
7
A Case of Childhood Severe Paroxysmal Cold Hemoglobinuria with Acute Renal Failure Successfully Treated with Plasma Exchange and Eculizumab
Published 2022-01-01“…She was successfully treated with plasma exchange and eculizumab, a humanized monoclonal antibody targeting complement protein C5, and demonstrated significant improvement of hemolysis and recovery of renal function.…”
Get full text
Article -
8
Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
Published 2021-01-01“…Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). …”
Get full text
Article -
9
Evolocumab-induced delayed skin hypersensitivity reaction in a patient with familial hypercholesterolaemia
Published 2024-02-01“…In this report, we describe a patient with a delayed cutaneous hypersensitivity reaction to evolocumab, a human monoclonal antibody directed against the serine protease proprotein convertase subtilisin/kexin type 9 used to reduce low-density lipoprotein concentrations in the treatment of familial hypercholesterolaemia. …”
Get full text
Article -
10
Trastuzumab Resistance: Role for Notch Signaling
Published 2009-01-01“…Trastuzumab, the humanized, monoclonal antibody directed against ErbB-2 has shown tremendous efficacy and improved overall survival for women when combined with a taxane-based chemotherapy. …”
Get full text
Article -
11
Purification and Analysis of the CREPT Antibody from Mouse Ascites
Published 2022-01-01“…This method is simple to perform and lays a foundation for the preparation and purification of humanized monoclonal antibodies in the future. In addition, it provides a basis for further research to investigate how CREPT affects the occurrence and development of different tumors.…”
Get full text
Article -
12
Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
Published 2012-01-01“…Pegaptanib sodium, which is an aptamer and ranibizumab, which is a monoclonal antibody fragment. Another humanized monoclonal antibody is currently off-label used, bevacizumab. …”
Get full text
Article -
13
New Possibilities for the Treatment of Crohn’s Disease
Published 2019-12-01“…Ustekinumab is a fully human monoclonal antibody of the IgG1k class to the p40 subunit of IL-12 and IL-23. …”
Get full text
Article -
14
Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review
Published 2016-01-01“…Daratumumab is the first-in-class human monoclonal antibody against CD38 cells which was studied in phase I/II trials for treatment of these patients with relapsed refractory multiple myeloma. …”
Get full text
Article -
15
Respiratory Syncytial Virus Infections in Infants Affected by Primary Immunodeficiency
Published 2014-01-01“…Prophylaxis with palivizumab, a humanized monoclonal antibody against the RSV F protein, is currently recommended in high-risk infants born prematurely, with chronic lung disease or congenital heart disease. …”
Get full text
Article -
16
Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
Published 2013-01-01“…Another bone-targeted agent is denosumab which is a fully humanized monoclonal antibody that binds to the RANK-L thereby inhibiting RANK-L mediated bone resorption. …”
Get full text
Article -
17
Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Age...
Published 2020-01-01“…Secukinumab (Cosentyx), a fully-human monoclonal antibody that acts by selectively binding to and neutralising the proinflammatory cytokine IL-17A, is used widely for the treatment of both chronic plaque psoriasis and psoriatic arthritis. …”
Get full text
Article -
18
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective
Published 2014-01-01“…Palivizumab, a humanized monoclonal antibody, has been recommended for high risk infants to prevent severe RSV-associated respiratory illness. …”
Get full text
Article -
19
Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis
Published 2025-01-01“…BackgroundOfatumumab, a fully human monoclonal antibody targeting CD20, is approved for the treatment of relapsing multiple sclerosis. …”
Get full text
Article -
20
The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
Published 2025-01-01“…BackgroundOfatumumab is a humanized monoclonal antibody that targets CD20-positive B cells. …”
Get full text
Article